Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial

Archive ouverte : Article de revue

Gallien, Philippe | Amarenco, Gérard | Benoit, Nicolas | Bonniaud, Véronique | Donzé, Cécile | Kerdraon, Jacques | Seze, Marianne, | Denys, Pierre | Renault, Alain | Naudet, Florian | Reymann, Jean Michel

Edité par HAL CCSD ; SAGE Publications

International audience. OBJECTIVE: Our aim was to assess the usefulness of cranberry extract in multiple sclerosis (MS) patients suffering from urinary disorders. METHODS: In total, 171 adult MS outpatients with urinary disorders presenting at eight centers were randomized (stratification according to center and use of clean intermittent self-catheterization) to cranberry versus placebo in a 1-year, prospective, double-blind study that was analyzed using a sequential method on an intent-to-treat basis. An independent monitoring board analyzed the results of the analyses each time 40 patients were assessed on the main endpoint. Cranberry extract (36 mg proanthocyanidins per day) or a matching placebo was taken by participants twice daily for 1 year. The primary endpoint was the time to first symptomatic urinary tract infection (UTI), subject to validation by a validation committee. RESULTS: The second sequential analyses allowed us to accept the null hypothesis (no difference between cranberry and placebo). There was no difference in time to first symptomatic UTI distribution across 1 year, with an estimated hazard ratio of 0.99, 95% CI [0.61, 1.60] (p = 0.97). Secondary endpoints and tolerance did not differ between groups. CONCLUSION: Taking cranberry extract versus placebo twice a day did not prevent UTI occurrence in MS patients with urinary disorders. Trial Registration NCT00280592.

Consulter en ligne

Suggestions

Du même auteur

MSCopilot: New smartphone-based digital biomarkers correlate with Expanded ...

Archive ouverte: Article de revue

Tanoh, Ian-Christopher | 2021-10

International audience. Background: A previous clinical study showed the high specificity, sensitivity and reliability of MSCopilot, a software medical device designed by Ad Scientiam for the self-assessment of peop...

Tout l'ECN / [coordination] Jean Lemoine..., Florian Naudet..., Eric Bellis...

Livre | Lemoine, Jean (19..-....) - interne en hématologie. Directeur de publication | 2021

Automatic Assessment of Expanded Disability Status Scale (EDSS) in Multiple...

Archive ouverte: Communication dans un congrès

Cao, Hua | 2012-05-17

International audience. The expanded disability status scale (EDSS) is frequently used to classify the patients with multiple sclerosis (MS). We presented in this paper a novel method to automatically assess the EDS...

Du même sujet

Ankle dysfunction in multiple sclerosis and the effects on walking

Archive ouverte: Article de revue

Massot, Caroline | 2021-08-14

International audience. Purpose: Even in the early stage of the disease, for patients suffering from multiple sclerosis (MS), the most common and reported biomechanical alterations in the lower limb are located at t...

Low back pain in patients with multiple sclerosis: A systematic review and ...

Archive ouverte: Article de revue

Massot, Caroline | 2021-04

International audience. PurposeThe prevalence and management of back pain in MS patients was assessed by a systematic review, and the results of a survey on the characteristics of low back pain in a sample of French...

Pregnancy and multiple sclerosis: 2022 recommendations from the French mult...

Archive ouverte: Article de revue

Vukusic, Sandra | 2023-01

International audience. Objective: The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS). Background: MS typically affects young w...

Urinary tract infections and multiple sclerosis: Recommendations from the F...

Archive ouverte: Article de revue

Donzé, C. | 2020-12

International audience. Objectives: Establish recommendations for the management of UTIs in MS patients.Background: Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of the most c...

Treating asymptomatic bacteriuria before immunosuppressive therapy during m...

Archive ouverte: Article de revue

Rouzaud, Claire | 2017-11

International audience

Proteolytic activity of Lactobacillus strains isolated from Mongolian tradi...

Archive ouverte: Article de revue

Raveschot, Cyril | 2020-01-30

Chargement des enrichissements...